Koen Maria Schrijnemakers

Title: Koen Maria Schrijnemakers: Innovator in Esketamine Formulations

Introduction

Koen Maria Schrijnemakers is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of esketamine formulations. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

Latest Patents

Schrijnemakers holds a patent for "Esketamine formulations and methods for preparation and storage." This patent focuses on pharmaceutical compositions that include esketamine or its pharmaceutically acceptable salts, along with an oxidative degradant. Notably, the oxidative degradant can be 6-(2-chlorophenyl)-6-oxohexanoic acid or a pharmaceutically acceptable salt thereof. The patent also outlines methods to limit the formation of oxidative degradants in these compositions, which is crucial for maintaining the efficacy and safety of the medication.

Career Highlights

Throughout his career, Koen Maria Schrijnemakers has been associated with Janssen Pharmaceutica NV, a leading pharmaceutical company. His work there has allowed him to focus on innovative solutions that address critical healthcare needs. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Schrijnemakers has collaborated with several professionals in his field, including Caroline Anne Aerts and Kris Kayens. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Koen Maria Schrijnemakers exemplifies the spirit of innovation in the pharmaceutical industry through his work on esketamine formulations. His contributions not only enhance the understanding of pharmaceutical compositions but also pave the way for improved treatment options in healthcare.